Russians Warned to Abstain from Drinking Alcohol After Getting Sputnik V COVID-19 Vaccine

by Rishma Parpia

Published December 21, 2020 | Vaccination, Risk & Failure Reports

Story Highlights

• Health officials in Russia tell Russians to avoid drinking alcohol two weeks prior to and 42 days after receiving the emergency use Sputnik V COVID-19 vaccine
• The Sputnik V manufacturer’s alcohol warning contradicts That of Russian health officials.
• The manufacturer recommends refraining from alcohol three days after each of the two doses of the vaccine.

Russian government health officials are warning their citizens to avoid consuming alcohol for 42 days after receiving the country’s emergency use COVID-19 vaccine known as Sputnik V.¹ Sputnik V is administered in two doses 21 days apart.² Health officials are also warning against smoking before and

after vaccination because tobacco smoke irritates the lungs and alters the body’s immune response.³

Health officials estimate that 100,000 Russians have received Sputnik V including military members.⁴

According to the World Health Organization (WHO), Russia is the fourth largest consumer of alcohol per person in the world, vodka being the national drink. The average Russian consumes 15.1 liters (almost four gallons) of alcohol per year.⁵

Russian Officials Warn Vaccine Recipients Against Alcohol Consumption

Ana Popova, head of Rospotrebnadzor, The Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing in Russia, said that people should stop drinking alcohol at least two weeks before getting the first two injections.⁶ Popova warned consuming alcohol before and after receiving the vaccine alcohol would reduce the body’s ability to build up immunity to the SARS-CoV-2 virus. She stated, “It’s a strain on the body. If we want to be healthy and have a strong immune response, don’t drink alcohol.”⁷

Russia’s Deputy Prime Minister Tatiana Golikova warned that Russians who receive the vaccine would have to take extra precautions during the 42 days following vaccination. She said;

[Russians] will have to refrain from visiting crowded places, wear face masks, use sanitizers, minimize contacts and refrain from drinking alcohol or taking immunosuppressant drugs.⁸

“Do Not Drink Alcohol” Warning from Sputnik V Manufacturer

Russian state-run Gamaleya Research Institute of Epidemiology and Microbiology that developed Sputnik V differ in their recommendation on alcohol consumption prior to and after vaccination.⁹ Alexandr Guinstburg, director of the Gamaleya Centre of Epidemiology and Microbiology said:

Under no circumstances should you get drunk, including during the vaccination process, as alcohol has a negative influence not only on a person’s behavior but also on the functioning of the immune system, but a glass of champagne does not harm anyone.¹⁰

He adds that, “But one glass of vodka will. Just 1 per cent of alcohol in the body has a “very negative” impact on the effectiveness of the vaccine.”¹¹

Guinstburg recommends not drinking alcohol three days after each of the two injections of the vaccine.¹²

Sputnik V Adenovirus Vaccine Will Be Tested in UAE, India, Venezuala, Belarus

The Russian COVID-19 vaccine Sputnik V developed by Gamaleya Research Institute of Epidemiology and Microbiology is an adenoviral-based vaccine against the SARS-CoV-2 virus. Sputnik V uses an attenuated virus to stimulate an immune response.¹³

Sputnik V is a vector vaccine based on adenovirus DNA, in which the SARS-CoV-2 coronavirus gene is integrated. An adenovirus is used as a “vehicle” to deliver the SARS-CoV-2 gene to cells and start the synthesis of the envelope proteins of the novel coronavirus, by “introducing” the immune system to the potential pathogen.¹⁴

According to the Sputnik V website, the ongoing Sputnik V post-registration clinical trial in Russia involves 40,000 volunteers. Clinical trials of Sputnik V have been announced in the United Arab Emirates, India, Venezuela and Belarus. The efficacy of the Sputnik V vaccine is 91.4 percent based on the second interim analysis of data obtained 28 days after administering the first dose and 7 days after the second dose.¹⁵

AstraZeneca to Partner With Russian Scientists to Investigate Combining Their COVID-19 Vaccines

British pharmaceutical AstraZeneca announced it would soon start working in collaboration with Russia’s Gamaleya Research Institute of Epidemiology and Microbiology to investigate whether their two COVID-19 vaccine candidates, both based on adenovirus vectors, could be combined.¹⁶

AstraZeneca issued the following statement:

Being able to combine different COVID-19 vaccines may be helpful to improved protection and/or to improve vaccine accessibility. This why it is important to explore different vaccine combinations to help make immunization programs more flexible, by allowing physicians greater choice at the time of administering vaccines. It is also likely that combining vaccines may lead to improved immunity over a longer-period of time.¹⁷

The Oxford University and AstraZeneca COVID-19 vaccine candidate uses a chimpanzee adenovirus viral vector to trigger expression of the characteristic spike protein of SARS-CoV-2.¹⁸

---

Click here to view References:

  Alexandr Guinstburg, Ana Popova, AstraZeneca, COVID-19, DNA, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Gamaleya Research Institute of Epidemiology and Microbiology, National Vaccine Information Center, NVIC, Oxford University, Rishma Parpia, Rospotrebnadzor, Russia, SARS-CoV-2, Sputnik V, Tatiana Golikova, The Vaccine Reaction, WHO, World Health Organization